PF-Atlas › Clinical Trials › NCT02871401
A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis
Valganciclovir · Phase 1
Registry ID
NCT02871401
Phase
Phase 1
Status
Completed
Drug / intervention
Valganciclovir
Sponsor
Vanderbilt University Medical Center
Start
2018-01-03
About this trial
Valganciclovir is evaluated in NCT02871401, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Vanderbilt University Medical Center. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02871401 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.